Global and China Oxaliplatin Market Size, Status and Forecast 2021-2027

Global and China Oxaliplatin Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oxaliplatin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mannitol
1.2.3 Glucose Solution
1.2.4 Lactose Solution
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oxaliplatin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Colorectal Cancer
1.3.3 Stomach Cancer
1.3.4 Ovarian Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oxaliplatin Market Perspective (2016-2027)
2.2 Oxaliplatin Growth Trends by Regions
2.2.1 Oxaliplatin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oxaliplatin Historic Market Share by Regions (2016-2021)
2.2.3 Oxaliplatin Forecasted Market Size by Regions (2022-2027)
2.3 Oxaliplatin Industry Dynamic
2.3.1 Oxaliplatin Market Trends
2.3.2 Oxaliplatin Market Drivers
2.3.3 Oxaliplatin Market Challenges
2.3.4 Oxaliplatin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oxaliplatin Players by Revenue
3.1.1 Global Top Oxaliplatin Players by Revenue (2016-2021)
3.1.2 Global Oxaliplatin Revenue Market Share by Players (2016-2021)
3.2 Global Oxaliplatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oxaliplatin Revenue
3.4 Global Oxaliplatin Market Concentration Ratio
3.4.1 Global Oxaliplatin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oxaliplatin Revenue in 2020
3.5 Oxaliplatin Key Players Head office and Area Served
3.6 Key Players Oxaliplatin Product Solution and Service
3.7 Date of Enter into Oxaliplatin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oxaliplatin Breakdown Data by Type
4.1 Global Oxaliplatin Historic Market Size by Type (2016-2021)
4.2 Global Oxaliplatin Forecasted Market Size by Type (2022-2027)
5 Oxaliplatin Breakdown Data by Application
5.1 Global Oxaliplatin Historic Market Size by Application (2016-2021)
5.2 Global Oxaliplatin Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Oxaliplatin Market Size (2016-2027)
6.2 North America Oxaliplatin Market Size by Type
6.2.1 North America Oxaliplatin Market Size by Type (2016-2021)
6.2.2 North America Oxaliplatin Market Size by Type (2022-2027)
6.2.3 North America Oxaliplatin Market Size by Type (2016-2027)
6.3 North America Oxaliplatin Market Size by Application
6.3.1 North America Oxaliplatin Market Size by Application (2016-2021)
6.3.2 North America Oxaliplatin Market Size by Application (2022-2027)
6.3.3 North America Oxaliplatin Market Size by Application (2016-2027)
6.4 North America Oxaliplatin Market Size by Country
6.4.1 North America Oxaliplatin Market Size by Country (2016-2021)
6.4.2 North America Oxaliplatin Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Oxaliplatin Market Size (2016-2027)
7.2 Europe Oxaliplatin Market Size by Type
7.2.1 Europe Oxaliplatin Market Size by Type (2016-2021)
7.2.2 Europe Oxaliplatin Market Size by Type (2022-2027)
7.2.3 Europe Oxaliplatin Market Size by Type (2016-2027)
7.3 Europe Oxaliplatin Market Size by Application
7.3.1 Europe Oxaliplatin Market Size by Application (2016-2021)
7.3.2 Europe Oxaliplatin Market Size by Application (2022-2027)
7.3.3 Europe Oxaliplatin Market Size by Application (2016-2027)
7.4 Europe Oxaliplatin Market Size by Country
7.4.1 Europe Oxaliplatin Market Size by Country (2016-2021)
7.4.2 Europe Oxaliplatin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Oxaliplatin Market Size (2016-2027)
8.2 Asia-Pacific Oxaliplatin Market Size by Type
8.2.1 Asia-Pacific Oxaliplatin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oxaliplatin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oxaliplatin Market Size by Type (2016-2027)
8.3 Asia-Pacific Oxaliplatin Market Size by Application
8.3.1 Asia-Pacific Oxaliplatin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oxaliplatin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oxaliplatin Market Size by Application (2016-2027)
8.4 Asia-Pacific Oxaliplatin Market Size by Region
8.4.1 Asia-Pacific Oxaliplatin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oxaliplatin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oxaliplatin Market Size (2016-2027)
9.2 Latin America Oxaliplatin Market Size by Type
9.2.1 Latin America Oxaliplatin Market Size by Type (2016-2021)
9.2.2 Latin America Oxaliplatin Market Size by Type (2022-2027)
9.2.3 Latin America Oxaliplatin Market Size by Type (2016-2027)
9.3 Latin America Oxaliplatin Market Size by Application
9.3.1 Latin America Oxaliplatin Market Size by Application (2016-2021)
9.3.2 Latin America Oxaliplatin Market Size by Application (2022-2027)
9.3.3 Latin America Oxaliplatin Market Size by Application (2016-2027)
9.4 Latin America Oxaliplatin Market Size by Country
9.4.1 Latin America Oxaliplatin Market Size by Country (2016-2021)
9.4.2 Latin America Oxaliplatin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oxaliplatin Market Size (2016-2027)
10.2 Middle East & Africa Oxaliplatin Market Size by Type
10.2.1 Middle East & Africa Oxaliplatin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oxaliplatin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oxaliplatin Market Size by Type (2016-2027)
10.3 Middle East & Africa Oxaliplatin Market Size by Application
10.3.1 Middle East & Africa Oxaliplatin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oxaliplatin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oxaliplatin Market Size by Application (2016-2027)
10.4 Middle East & Africa Oxaliplatin Market Size by Country
10.4.1 Middle East & Africa Oxaliplatin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oxaliplatin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Company Details
11.1.2 Sanofi-Aventis Business Overview
11.1.3 Sanofi-Aventis Oxaliplatin Introduction
11.1.4 Sanofi-Aventis Revenue in Oxaliplatin Business (2016-2021)
11.1.5 Sanofi-Aventis Recent Development
11.2 Yakult honsha
11.2.1 Yakult honsha Company Details
11.2.2 Yakult honsha Business Overview
11.2.3 Yakult honsha Oxaliplatin Introduction
11.2.4 Yakult honsha Revenue in Oxaliplatin Business (2016-2021)
11.2.5 Yakult honsha Recent Development
11.3 Dr Reddy's laboratories
11.3.1 Dr Reddy's laboratories Company Details
11.3.2 Dr Reddy's laboratories Business Overview
11.3.3 Dr Reddy's laboratories Oxaliplatin Introduction
11.3.4 Dr Reddy's laboratories Revenue in Oxaliplatin Business (2016-2021)
11.3.5 Dr Reddy's laboratories Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Details
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Oxaliplatin Introduction
11.4.4 Sun Pharmaceutical Revenue in Oxaliplatin Business (2016-2021)
11.4.5 Sun Pharmaceutical Recent Development
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Oxaliplatin Introduction
11.5.4 Teva Revenue in Oxaliplatin Business (2016-2021)
11.5.5 Teva Recent Development
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Details
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Oxaliplatin Introduction
11.6.4 Fresenius Kabi Revenue in Oxaliplatin Business (2016-2021)
11.6.5 Fresenius Kabi Recent Development
11.7 Hospira
11.7.1 Hospira Company Details
11.7.2 Hospira Business Overview
11.7.3 Hospira Oxaliplatin Introduction
11.7.4 Hospira Revenue in Oxaliplatin Business (2016-2021)
11.7.5 Hospira Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan Oxaliplatin Introduction
11.8.4 Mylan Revenue in Oxaliplatin Business (2016-2021)
11.8.5 Mylan Recent Development
11.9 Jiangsu Hengrui Medicine
11.9.1 Jiangsu Hengrui Medicine Company Details
11.9.2 Jiangsu Hengrui Medicine Business Overview
11.9.3 Jiangsu Hengrui Medicine Oxaliplatin Introduction
11.9.4 Jiangsu Hengrui Medicine Revenue in Oxaliplatin Business (2016-2021)
11.9.5 Jiangsu Hengrui Medicine Recent Development
11.10 Nanjing Pharmaceutical Factory
11.10.1 Nanjing Pharmaceutical Factory Company Details
11.10.2 Nanjing Pharmaceutical Factory Business Overview
11.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Introduction
11.10.4 Nanjing Pharmaceutical Factory Revenue in Oxaliplatin Business (2016-2021)
11.10.5 Nanjing Pharmaceutical Factory Recent Development
11.11 Jiangsu Aosaikang Pharmaceutical
11.11.1 Jiangsu Aosaikang Pharmaceutical Company Details
11.11.2 Jiangsu Aosaikang Pharmaceutical Business Overview
11.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Introduction
11.11.4 Jiangsu Aosaikang Pharmaceutical Revenue in Oxaliplatin Business (2016-2021)
11.11.5 Jiangsu Aosaikang Pharmaceutical Recent Development
11.12 Qilu Pharmaceutical
11.12.1 Qilu Pharmaceutical Company Details
11.12.2 Qilu Pharmaceutical Business Overview
11.12.3 Qilu Pharmaceutical Oxaliplatin Introduction
11.12.4 Qilu Pharmaceutical Revenue in Oxaliplatin Business (2016-2021)
11.12.5 Qilu Pharmaceutical Recent Development
11.13 Hisun Pharmaceutical
11.13.1 Hisun Pharmaceutical Company Details
11.13.2 Hisun Pharmaceutical Business Overview
11.13.3 Hisun Pharmaceutical Oxaliplatin Introduction
11.13.4 Hisun Pharmaceutical Revenue in Oxaliplatin Business (2016-2021)
11.13.5 Hisun Pharmaceutical Recent Development
11.14 Lunan Pharmaceutical
11.14.1 Lunan Pharmaceutical Company Details
11.14.2 Lunan Pharmaceutical Business Overview
11.14.3 Lunan Pharmaceutical Oxaliplatin Introduction
11.14.4 Lunan Pharmaceutical Revenue in Oxaliplatin Business (2016-2021)
11.14.5 Lunan Pharmaceutical Recent Development
11.15 Luoxin
11.15.1 Luoxin Company Details
11.15.2 Luoxin Business Overview
11.15.3 Luoxin Oxaliplatin Introduction
11.15.4 Luoxin Revenue in Oxaliplatin Business (2016-2021)
11.15.5 Luoxin Recent Development
11.16 Halfsky Pharmacy
11.16.1 Halfsky Pharmacy Company Details
11.16.2 Halfsky Pharmacy Business Overview
11.16.3 Halfsky Pharmacy Oxaliplatin Introduction
11.16.4 Halfsky Pharmacy Revenue in Oxaliplatin Business (2016-2021)
11.16.5 Halfsky Pharmacy Recent Development
11.17 YRPG
11.17.1 YRPG Company Details
11.17.2 YRPG Business Overview
11.17.3 YRPG Oxaliplatin Introduction
11.17.4 YRPG Revenue in Oxaliplatin Business (2016-2021)
11.17.5 YRPG Recent Development
11.18 Hainan Jinrui Pharmaceutical
11.18.1 Hainan Jinrui Pharmaceutical Company Details
11.18.2 Hainan Jinrui Pharmaceutical Business Overview
11.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Introduction
11.18.4 Hainan Jinrui Pharmaceutical Revenue in Oxaliplatin Business (2016-2021)
11.18.5 Hainan Jinrui Pharmaceutical Recent Development
11.18 Jari Pharmaceutical
.1 Jari Pharmaceutical Company Details
.2 Jari Pharmaceutical Business Overview
.3 Jari Pharmaceutical Oxaliplatin Introduction
.4 Jari Pharmaceutical Revenue in Oxaliplatin Business (2016-2021)
.5 Jari Pharmaceutical Recent Development
11.20 Chiatai Tianqing
11.20.1 Chiatai Tianqing Company Details
11.20.2 Chiatai Tianqing Business Overview
11.20.3 Chiatai Tianqing Oxaliplatin Introduction
11.20.4 Chiatai Tianqing Revenue in Oxaliplatin Business (2016-2021)
11.20.5 Chiatai Tianqing Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Oxaliplatin Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mannitol
Table 3. Key Players of Glucose Solution
Table 4. Key Players of Lactose Solution
Table 5. Key Players of Others
Table 6. Global Oxaliplatin Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Oxaliplatin Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Oxaliplatin Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Oxaliplatin Market Share by Regions (2016-2021)
Table 10. Global Oxaliplatin Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Oxaliplatin Market Share by Regions (2022-2027)
Table 12. Oxaliplatin Market Trends
Table 13. Oxaliplatin Market Drivers
Table 14. Oxaliplatin Market Challenges
Table 15. Oxaliplatin Market Restraints
Table 16. Global Oxaliplatin Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Oxaliplatin Market Share by Players (2016-2021)
Table 18. Global Top Oxaliplatin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxaliplatin as of 2020)
Table 19. Ranking of Global Top Oxaliplatin Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Oxaliplatin Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Oxaliplatin Product Solution and Service
Table 23. Date of Enter into Oxaliplatin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oxaliplatin Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Oxaliplatin Revenue Market Share by Type (2016-2021)
Table 27. Global Oxaliplatin Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Oxaliplatin Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Oxaliplatin Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Oxaliplatin Revenue Market Share by Application (2016-2021)
Table 31. Global Oxaliplatin Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Oxaliplatin Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Oxaliplatin Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Oxaliplatin Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Oxaliplatin Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Oxaliplatin Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Oxaliplatin Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Oxaliplatin Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Oxaliplatin Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Oxaliplatin Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Oxaliplatin Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Oxaliplatin Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Oxaliplatin Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Oxaliplatin Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Oxaliplatin Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Oxaliplatin Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Oxaliplatin Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Oxaliplatin Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Oxaliplatin Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Oxaliplatin Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Oxaliplatin Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Oxaliplatin Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Oxaliplatin Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Oxaliplatin Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Oxaliplatin Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Oxaliplatin Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Oxaliplatin Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Oxaliplatin Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Oxaliplatin Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Oxaliplatin Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Oxaliplatin Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Oxaliplatin Market Size by Country (2022-2027) & (US$ Million)
Table 63. Sanofi-Aventis Company Details
Table 64. Sanofi-Aventis Business Overview
Table 65. Sanofi-Aventis Oxaliplatin Product
Table 66. Sanofi-Aventis Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 67. Sanofi-Aventis Recent Development
Table 68. Yakult honsha Company Details
Table 69. Yakult honsha Business Overview
Table 70. Yakult honsha Oxaliplatin Product
Table 71. Yakult honsha Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 72. Yakult honsha Recent Development
Table 73. Dr Reddy's laboratories Company Details
Table 74. Dr Reddy's laboratories Business Overview
Table 75. Dr Reddy's laboratories Oxaliplatin Product
Table 76. Dr Reddy's laboratories Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 77. Dr Reddy's laboratories Recent Development
Table 78. Sun Pharmaceutical Company Details
Table 79. Sun Pharmaceutical Business Overview
Table 80. Sun Pharmaceutical Oxaliplatin Product
Table 81. Sun Pharmaceutical Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 82. Sun Pharmaceutical Recent Development
Table 83. Teva Company Details
Table 84. Teva Business Overview
Table 85. Teva Oxaliplatin Product
Table 86. Teva Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 87. Teva Recent Development
Table 88. Fresenius Kabi Company Details
Table 89. Fresenius Kabi Business Overview
Table 90. Fresenius Kabi Oxaliplatin Product
Table 91. Fresenius Kabi Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 92. Fresenius Kabi Recent Development
Table 93. Hospira Company Details
Table 94. Hospira Business Overview
Table 95. Hospira Oxaliplatin Product
Table 96. Hospira Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 97. Hospira Recent Development
Table 98. Mylan Company Details
Table 99. Mylan Business Overview
Table 100. Mylan Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 101. Mylan Recent Development
Table 102. Jiangsu Hengrui Medicine Company Details
Table 103. Jiangsu Hengrui Medicine Business Overview
Table 104. Jiangsu Hengrui Medicine Oxaliplatin Product
Table 105. Jiangsu Hengrui Medicine Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 106. Jiangsu Hengrui Medicine Recent Development
Table 107. Nanjing Pharmaceutical Factory Company Details
Table 108. Nanjing Pharmaceutical Factory Business Overview
Table 109. Nanjing Pharmaceutical Factory Oxaliplatin Product
Table 110. Nanjing Pharmaceutical Factory Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 111. Nanjing Pharmaceutical Factory Recent Development
Table 112. Jiangsu Aosaikang Pharmaceutical Company Details
Table 113. Jiangsu Aosaikang Pharmaceutical Business Overview
Table 114. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product
Table 115. Jiangsu Aosaikang Pharmaceutical Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 116. Jiangsu Aosaikang Pharmaceutical Recent Development
Table 117. Qilu Pharmaceutical Company Details
Table 118. Qilu Pharmaceutical Business Overview
Table 119. Qilu Pharmaceutical Oxaliplatin Product
Table 120. Qilu Pharmaceutical Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 121. Qilu Pharmaceutical Recent Development
Table 122. Hisun Pharmaceutical Company Details
Table 123. Hisun Pharmaceutical Business Overview
Table 124. Hisun Pharmaceutical Oxaliplatin Product
Table 125. Hisun Pharmaceutical Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 126. Hisun Pharmaceutical Recent Development
Table 127. Lunan Pharmaceutical Company Details
Table 128. Lunan Pharmaceutical Business Overview
Table 129. Lunan Pharmaceutical Oxaliplatin Product
Table 130. Lunan Pharmaceutical Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 131. Lunan Pharmaceutical Recent Development
Table 132. Luoxin Company Details
Table 133. Luoxin Business Overview
Table 134. Luoxin Oxaliplatin Product
Table 135. Luoxin Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 136. Luoxin Recent Development
Table 137. Halfsky Pharmacy Company Details
Table 138. Halfsky Pharmacy Business Overview
Table 139. Halfsky Pharmacy Oxaliplatin Product
Table 140. Halfsky Pharmacy Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 141. Halfsky Pharmacy Recent Development
Table 142. YRPG Company Details
Table 143. YRPG Business Overview
Table 144. YRPG Oxaliplatin Product
Table 145. YRPG Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 146. YRPG Recent Development
Table 147. Hainan Jinrui Pharmaceutical Company Details
Table 148. Hainan Jinrui Pharmaceutical Business Overview
Table 149. Hainan Jinrui Pharmaceutical Oxaliplatin Product
Table 150. Hainan Jinrui Pharmaceutical Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 151. Hainan Jinrui Pharmaceutical Recent Development
Table 152. Jari Pharmaceutical Company Details
Table 153. Jari Pharmaceutical Business Overview
Table 154. Jari Pharmaceutical Oxaliplatin Product
Table 155. Jari Pharmaceutical Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 156. Jari Pharmaceutical Recent Development
Table 157. Chiatai Tianqing Company Details
Table 158. Chiatai Tianqing Business Overview
Table 159. Chiatai Tianqing Oxaliplatin Product
Table 160. Chiatai Tianqing Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 161. Chiatai Tianqing Recent Development
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oxaliplatin Market Share by Type: 2020 VS 2027
Figure 2. Mannitol Features
Figure 3. Glucose Solution Features
Figure 4. Lactose Solution Features
Figure 5. Others Features
Figure 6. Global Oxaliplatin Market Share by Application: 2020 VS 2027
Figure 7. Colorectal Cancer Case Studies
Figure 8. Stomach Cancer Case Studies
Figure 9. Ovarian Cancer Case Studies
Figure 10. Others Case Studies
Figure 11. Oxaliplatin Report Years Considered
Figure 12. Global Oxaliplatin Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Oxaliplatin Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Oxaliplatin Market Share by Regions: 2020 VS 2027
Figure 15. Global Oxaliplatin Market Share by Regions (2022-2027)
Figure 16. Global Oxaliplatin Market Share by Players in 2020
Figure 17. Global Top Oxaliplatin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxaliplatin as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Oxaliplatin Revenue in 2020
Figure 19. Global Oxaliplatin Revenue Market Share by Type (2016-2021)
Figure 20. Global Oxaliplatin Revenue Market Share by Type (2022-2027)
Figure 21. North America Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Oxaliplatin Market Share by Type (2016-2027)
Figure 23. North America Oxaliplatin Market Share by Application (2016-2027)
Figure 24. North America Oxaliplatin Market Share by Country (2016-2027)
Figure 25. United States Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Oxaliplatin Market Share by Type (2016-2027)
Figure 29. Europe Oxaliplatin Market Share by Application (2016-2027)
Figure 30. Europe Oxaliplatin Market Share by Country (2016-2027)
Figure 31. Germany Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Oxaliplatin Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Oxaliplatin Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Oxaliplatin Market Share by Region (2016-2027)
Figure 41. China Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Oxaliplatin Market Share by Type (2016-2027)
Figure 49. Latin America Oxaliplatin Market Share by Application (2016-2027)
Figure 50. Latin America Oxaliplatin Market Share by Country (2016-2027)
Figure 51. Mexico Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Oxaliplatin Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Oxaliplatin Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Oxaliplatin Market Share by Country (2016-2027)
Figure 57. Turkey Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Sanofi-Aventis Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 61. Yakult honsha Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 62. Dr Reddy's laboratories Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 63. Sun Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 64. Teva Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 65. Fresenius Kabi Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 66. Hospira Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 67. Mylan Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 68. Jiangsu Hengrui Medicine Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 69. Nanjing Pharmaceutical Factory Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 70. Jiangsu Aosaikang Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 71. Qilu Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 72. Hisun Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 73. Lunan Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 74. Luoxin Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 75. Halfsky Pharmacy Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 76. YRPG Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 77. Hainan Jinrui Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 78. Jari Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 79. Chiatai Tianqing Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs